Associate professor Peter Edman is using his scientific and leadership capabilities to drive forward development at pharma company Biovitrum in his new role as chief scientific officer.
He offers experience in both small molecules and biopharmaceuticals and "will be a great asset to the company, says Biovitrum's ceo Martin Nicklasson.